Sciclone Pharmaceuticals, Inc. (Nasdaq: SCLN) announced the Audit Committee of the Company's Board of Directors has appointed PricewaterhouseCoopers LLP as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE